会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • 5-PHENYL-THIAZOL-2-YL-UREA DERIVATIVES AND USE AS PI3 KINASE INHIBITORS
    • 5-苯基 - 噻唑-2-基-L-尿素衍生物,并用作PI3激酶抑制剂
    • US20090234132A1
    • 2009-09-17
    • US12227315
    • 2007-05-21
    • Emma BuddJudy Fox HaylerIan BruceDarren Mark LegrandBrian Cox
    • Emma BuddJudy Fox HaylerIan BruceDarren Mark LegrandBrian Cox
    • C07D277/46
    • C07D277/48C07D417/12
    • The present invention concerns a compound of formula Ia wherein: Ra* is hydrogen or C1-4-alkyl; Rb* is —(C1-C4-alkylene)-Y—C1-4-haloalkyl or —(C1-C4-alkylene)-Y—C1-C4-hydroxyalkyl; Y represents —CONH— or a five membered heteroaryl group. R2* is C1-C4-alkyl or halogen; R3* is halo, —SO2—CH3, —SO2—CF3, carboxy, —CO—NH2, —CO-di(C1-C8-alkyl)amino, or a 5- or 6-membered heterocyclic ring having one or more ring hetero atoms selected from the group consisting of oxygen, nitrogen and sulphur, that ring being optionally substituted by halo, cyano, oxo, hydroxy, carboxy, nitro, C3-C8-cycloalkyl, C1-C8-alkylcarbonyl, C1-C8-alkoxy optionally substituted by aminocarbonyl, or C1-C8-alkyl optionally substituted by hydroxy, C1-C8-alkoxy, C1-C8-alkylamino or di(C1-C8-alkyl)amino; R4* is hydrogen, halo, —SO2—CH3, nitrile, C1-C8-haloalkyl, imidazolyl, C1-C8-alkyl, —NR8*R9*, or —SO2—NR8*R9*; and R5* is hydrogen, halogen or C1-C8-alkyl; R8* and R9* are independently hydrogen, amino, C1-C8-alkylamino, di(C1-C8-alkyl)amino, or CC1-C8-alkyl optionally substituted by hydroxyl; or a pharmaceutically acceptable salt, or solvate thereof, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.
    • 本发明涉及式Ia化合物,其中:R a *是氢或C 1-4 - 烷基; Rb *是 - (C 1 -C 4 - 亚烷基)-Y-C 1-4 - 卤代烷基或 - (C 1 -C 4亚烷基)-Y-C 1 -C 4 - 羟基烷基; Y表示-CONH-或五元杂芳基。 R2 *是C1-C4-烷基或卤素; R3 *是卤素,-SO2-CH3,-SO2-CF3,羧基,-CO-NH2,-CO-二(C1-C8-烷基)氨基或具有一个或多个环的5-或6-元杂环 氰基,氧代,羟基,羧基,硝基,C 3 -C 8 - 环烷基,C 1 -C 8 - 烷基羰基,任选地被C 1 -C 8 - 烷氧基取代的C 1 -C 8 - 烷氧基 被氨基羰基取代,或任选被羟基,C 1 -C 8 - 烷氧基,C 1 -C 8 - 烷基氨基或二(C 1 -C 8 - 烷基)氨基取代的C 1 -C 8烷基; R4 *是氢,卤素,-SO2-CH3,腈,C1-C8-卤代烷基,咪唑基,C1-C8-烷基,-NR8 * R9 *或-SO2-NR8 * R9 * R5 *是氢,卤素或C1-C8-烷基; R 8 *和R 9 *独立地为氢,氨基,C 1 -C 8 - 烷基氨基,二(C 1 -C 8 - 烷基)氨基或任选被羟基取代的C 1 -C 8 - 烷基; 或其药学上可接受的盐或溶剂合物,用于治疗通过抑制磷脂酰肌醇3-激酶而改善的疾病的组合物和用途。
    • 4. 发明授权
    • 5-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors
    • 5-苯基 - 噻唑-2-基 - 脲衍生物,用作PI3激酶抑制剂
    • US07998990B2
    • 2011-08-16
    • US12227315
    • 2007-05-21
    • Emma BuddJudy Fox HaylerIan BruceDarren Mark LegrandBrian Cox
    • Emma BuddJudy Fox HaylerIan BruceDarren Mark LegrandBrian Cox
    • A61K31/426C07D277/42
    • C07D277/48C07D417/12
    • The present invention concerns a compound of formula Ia wherein: Ra* is hydrogen or C1-C4-alkyl; Rb* is —(C1-C4-alkylene)-Y—C1-C4-haloalkyl or —(C1-C4-alkylene)-Y—C1-C4-hydroxyalkyl; Y represents —CONH— or a five membered heteroaryl group. R2* is C1-C4-alkyl or halogen; R3* is halo, —SO2—CH3, —SO2—CF3, carboxy, —CO—NH2, —CO-di(C1-C8-alkyl)amino, or a 5- or 6-membered heterocyclic ring having one or more ring hetero atoms selected from the group consisting of oxygen, nitrogen and sulphur, that ring being optionally substituted by halo, cyano, oxo, hydroxy, carboxy, nitro, C3-C8-cycloalkyl, C1-C8-alkylcarbonyl, C1-C8-alkoxy optionally substituted by aminocarbonyl, or C1-C8-alkyl optionally substituted by hydroxy, C1-C8-alkoxy, C1-C8-alkylamino or di(C1-C8-alkyl)amino; R4* is hydrogen, halo, —SO2—CH3, nitrile, C1-C8-haloalkyl, imidazolyl, C1-C8-alkyl, —NR8*R9*, or —SO2—NR8*R9*; and R5* is hydrogen, halogen or C1-C8-alkyl; R8* and R9* are independently hydrogen, amino, C1-C8-alkylamino, di(C1-C8-alkyl)amino, or CC1-C8-alkyl optionally substituted by hydroxyl; or a pharmaceutically acceptable salt, or solvate thereof, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.
    • 本发明涉及式Ia化合物,其中:Ra *是氢或C 1 -C 4 - 烷基; Rb *是 - (C1-C4-亚烷基)-Y-C1-C4-卤代烷基或 - (C1-C4-亚烷基)-Y-C1-C4-羟基烷基; Y表示-CONH-或五元杂芳基。 R2 *是C1-C4-烷基或卤素; R3 *是卤素,-SO2-CH3,-SO2-CF3,羧基,-CO-NH2,-CO-二(C1-C8-烷基)氨基或具有一个或多个环的5-或6-元杂环 氰基,氧代,羟基,羧基,硝基,C 3 -C 8 - 环烷基,C 1 -C 8 - 烷基羰基,任选地被C 1 -C 8 - 烷氧基取代的C 1 -C 8 - 烷氧基 被氨基羰基取代,或任选被羟基,C 1 -C 8 - 烷氧基,C 1 -C 8 - 烷基氨基或二(C 1 -C 8 - 烷基)氨基取代的C 1 -C 8烷基; R4 *是氢,卤素,-SO2-CH3,腈,C1-C8-卤代烷基,咪唑基,C1-C8-烷基,-NR8 * R9 *或-SO2-NR8 * R9 * 和R5 *是氢,卤素或C1-C8-烷基; R 8 *和R 9 *独立地为氢,氨基,C 1 -C 8 - 烷基氨基,二(C 1 -C 8 - 烷基)氨基或任选被羟基取代的C 1 -C 8 - 烷基; 或其药学上可接受的盐或溶剂合物,用于治疗通过抑制磷脂酰肌醇3-激酶而改善的疾病的组合物和用途。